Malik is a senior partner leading work in Healthcare Business Transformation in Europe with a focus on Cell and Gene Therapy.
Malik has advised clients on some of the most successful molecules in the industry. He got his start in malignant haematology, working deeply with manufacturers in Multiple Myeloma, DLBCL, FL, and CLL. With his team, Malik developed the strategy and operational plan for one of the most commercially successful gene therapies in Europe.